🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To assess the safety, tolerability and pharmacokinetics of ABT-199 in femal...
Status
Completed
Location
Site Reference ID/Investigator# 89694
Start Date
2012-11
Trial ID
NCT01686555
This study is a biomedical, open label, therapeutic strategy, interventiona...
Status
Completed
Location
CH Hôpital Duchenne
Start Date
2014-12
Trial ID
NCT02364908
Treatments Being Tested
Lupus nephritis (LN) develops in 30-60% of systemic lupus erythematosus (SL...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-01
Trial ID
NCT07505576
Many laboratory markers can be measured for assessment of Lupus activity as...
Status
Unknown
Location
Sohag University Hospital
Start Date
2021-10-01
Trial ID
NCT05045417
Treatments Being Tested
In 2007-2009 the investigators conducted a study to determine the immunogen...
Status
Terminated
Location
Royal Childrens Hospital
Start Date
2012-03
Trial ID
NCT01896986
This is a first exploration of GLPG3970 in subjects with active systemic lu...
Status
Terminated
Location
Medical center Medconsult Pleven
Start Date
2020-12-28
Trial ID
NCT04700267
Treatments Being Tested
Based on clinical manifestations, laboratory data and intestinal microflora...
Status
Unknown
Location
Qin Huang
Start Date
2022-10-01
Trial ID
NCT05636670
Systemic lupus erythematosis (SLE) is a chronic autoimmune disease characte...
Status
Unknown
Location
Multiple Locations
Start Date
2022-02-22
Trial ID
NCT05253638
Treatments Being Tested
The goal of this clinical trial is to evaluate the safety and effectiveness...
Status
Recruiting
Location
Medical University of South Carolina
Start Date
2025-01-07
Trial ID
NCT06737380
Treatments Being Tested
This study will assess the effect of a 24-week withdrawal followed by a 28-...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-05-13
Trial ID
NCT02119156
Treatments Being Tested